MIT researchers have generated mature liver cells from induced pluripotent stem cells. In this image, the cell nuclei are stained blue. The green stain identifies liver cells, and the red stain identifies cells that are actively dividing. IMAGE: SHAN ET AL, NATURE CHEMICAL BIOLOGY, 2013
Researchers identify compounds that help liver cells grow outside the body.
Prometheus, the mythological figure who stole fire from the gods, was punished for this theft by being bound to a rock. Each day, an eagle swept down and fed on his liver, which then grew back to be eaten again the next day.
Modern scientists know there is a grain of truth to the tale, says MIT engineer Sangeeta Bhatia: The liver can indeed regenerate itself if part of it is removed. However, researchers trying to exploit that ability in hopes of producing artificial liver tissue for transplantation have repeatedly been stymied: Mature liver cells, known as hepatocytes, quickly lose their normal function when removed from the body.
“It’s a paradox because we know liver cells are capable of growing, but somehow we can’t get them to grow” outside the body, says Bhatia, the John and Dorothy Wilson Professor of Health Sciences and Technology and Electrical Engineering and Computer Science at MIT, a senior associate member of the Broad Institute and a member of MIT’s Koch Institute for Integrative Cancer Research and Institute for Medical Engineering and Science.
Now, Bhatia and colleagues have taken a step toward that goal. In a paper appearing in the June 2 issue of Nature Chemical Biology, they have identified a dozen chemical compounds that can help liver cells not only maintain their normal function while grown in a lab dish, but also multiply to produce new tissue.
Cells grown this way could help researchers develop engineered tissue to treat many of the 500 million people suffering from chronic liver diseases such as hepatitis C, according to the researchers.
The Latest Bing News on:
Artificial livers
- Artificial Wombs are Science Fiction: But Artificial Placentas are on the Horizonon April 10, 2021 at 12:11 am
Abstract: Even before a woman knows she's pregnant, the placenta swells in size, poised to serve as the fetus's kidneys and liver until the fetus has its own. The placenta starts to “breathe” for the ...
- Outlook on the Artificial Organ and Bionics Global Market to 2025 - Competitive Analysis and Impact of COVID-19on April 9, 2021 at 5:13 am
The "Global Artificial Organ and Bionics Market (2020-2025) by Type, Technology, End user, Geography, Competitive Analysis, Impact of Covid-19 and Ansoff Analysis" report has been added to ...
- SenseTime Receives CE Mark for its AI Medical Solution SenseCare-Chest DR Pro Diagnostic Softwareon April 8, 2021 at 12:01 am
KUALA LUMPUR, Malaysia, April 8, 2021 /PRNewswire/ -- SenseTime, the world-leading artificial intelligence (AI ... covering chest, cardiovascular, liver, pathology, orthopedics and radiotherapy. It ...
- Artificial Vital Organs and Medical Bionics Market Covid 19 Impact Assessment, Current Growth Status, Major Key Players|Abbott Diabetes Careon April 6, 2021 at 11:37 pm
Artificial liver, Artificial pancreas, Artificial lungs, Oxygenators, Heart-Lung bypass machines, Medical bionics, Ear bionics (cochlear implants), Vision bionics, Exoskeletons, Bionic limbs, Bionic ...
- Artificial Organs Market Size – Industry Share, Growth, Trends and Forecast 2027on April 6, 2021 at 5:29 pm
The market is experiencing rapid growth attributed to growing incidences of organ failure, especially kidney, liver, heart, lungs, and pancreas, among others. The primary benefits of artificial organs ...
- FDA gives green light to Vysioneer’s brain tumor autocontouring toolon April 6, 2021 at 3:37 pm
Vysioneer Inc. has won the FDA’s nod for its Vbrain artificial intelligence (AI)-powered tumor autocontouring software. The company said Vbrain is the first AI device to receive FDA clearance for ...
- Leveling the Playing Field in Detecting Athletics Drug Cheatson April 6, 2021 at 5:28 am
As the world awaits the upcoming Olympic games, a new method for detecting doping compounds in urine samples could level the playing field for those trying to keep athletics clean. An approach using ...
- A novel prognostic model to predict outcome of artificial liver support system treatmenton April 5, 2021 at 2:38 am
The prognosis of Artificial liver support system (ALSS) for hepatitis B virus-related acute-on-chronic liver failure (HBV-ACLF) is hard to be expected, which results in multiple operations of ALSS and ...
- The third generation of siRNA delivery system makes RNAi therapy feasibleon March 30, 2021 at 6:59 am
Researchers reprogram host liver with genetic circuits to direct the synthesis and self-assembly of siRNAs into secretory exosomes. In vivo assembled siRNAs are systematically distributed to multiple ...
- Novel Phenomics NASH In Vitro Assay Presented by InSphero AG and PharmaNest Inc at 2021 Society of Toxicology Meetingon March 29, 2021 at 2:24 pm
The company specializes in liver toxicology, metabolic diseases (e.g., T1 & T2 ... About PharmaNest, Inc PharmaNest is an Artificial Intelligence and Digital Pathology company focused in the ...
The Latest Google Headlines on:
Artificial livers
The Latest Bing News on:
Chronic liver diseases
- Pakistan's first liver autotransplantation procedure performed at DUHSon April 10, 2021 at 8:08 am
KARACHI: In a first for Pakistan, the Dow University of Health Sciences (DUHS), Karachi, performed a liver autotransplantation procedure successfully. The liver of a 28-year old patient, who was ...
- Significant Nonalcoholic Fatty Liver Disease, Fibrosis Risk Found in Patients With Obstructive Sleep Apneaon April 9, 2021 at 8:03 am
Approximately 45% of patients with obstructive sleep apnea were shown to present with nonalcoholic fatty liver disease, with age and weight indicated as significant predictors of high fibrosis score ...
- Deaths from liver diseases skyrocket in South Dakota amid COVID-19 pandemicon April 8, 2021 at 1:56 pm
For the last decade, yearly deaths from cirrhosis and liver disease have been ticking up. But 2020 saw the steepest jump yet.
- Chronic Liver Disease Market Poised for Growth | Key Players – Abbott Laboratories F. Hoffmann-La Roche AGon April 8, 2021 at 5:57 am
The Chronic Liver Disease market is expected to grow at a CAGR of 6.7% and is poised to reach $XX Billion by 2027 as compared to $XX Billion in 2020. The factors leading to this extraordinary growth ...
- Genetic variants of programmed cell death 1 are associated with HBV infection and liver disease progressionon April 8, 2021 at 3:00 am
The inhibitory effects of programmed cell death 1/programmed cell death ligand 1 (PD-1/PD-L1) modulates T-cell depletion. T-cell depletion is one of the key mechanisms of hepatitis B virus (HBV) ...
- Added Sugars May Contribute to Liver Disease in Childrenon April 7, 2021 at 11:27 am
The global rise of nonalcoholic fatty-liver disease in pediatric populations has highlighted the need to understand the potential cause of this growing trend.
- Bariatric Surgery May Cut Cancer in Obesity With Liver Diseaseon April 7, 2021 at 5:30 am
Among working adults with severe obesity and fatty liver disease, rates of cancer were lower for those who had bariatric surgery, especially those with obesity-related cancer, during a 10-month median ...
- Devastating liver disease itching turns out to have a surprising causeon April 5, 2021 at 6:44 pm
A devastating itching of the skin driven by severe liver disease turns out to have a surprising cause. Its discovery points toward possible new therapies for itching, and shows that the outer layer of ...
- Maddening itch of liver disease comes from a surprising sourceon April 5, 2021 at 9:48 am
A devastating itching of the skin driven by severe liver disease turns out to have a surprising cause. Its discovery points toward possible new therapies for itching, and shows that the outer layer of ...
- A novel prognostic model to predict outcome of artificial liver support system treatmenton April 5, 2021 at 2:38 am
The prognosis of Artificial liver support system (ALSS) for hepatitis B virus-related acute-on-chronic liver failure (HBV-ACLF) is hard to be expected, which results in multiple operations of ALSS and ...
